THERAFIDE Trademark

Trademark Overview

On Friday, October 1, 2004, a trademark application was filed for THERAFIDE with the United States Patent and Trademark Office. The USPTO has given the THERAFIDE trademark a serial number of 78493235. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, July 25, 2008. This trademark is owned by Amgen Inc.. The THERAFIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of injury to epithelial cells and tissues
therafide

General Information

Serial Number78493235
Word MarkTHERAFIDE
Filing DateFriday, October 1, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, July 25, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the treatment of injury to epithelial cells and tissues

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 8, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Thursday, September 25, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, September 25, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 12, 2008EXTENSION 4 GRANTED
Wednesday, January 23, 2008EXTENSION 4 FILED
Wednesday, January 23, 2008TEAS EXTENSION RECEIVED
Saturday, September 8, 2007EXTENSION 3 GRANTED
Monday, July 2, 2007EXTENSION 3 FILED
Monday, July 2, 2007TEAS EXTENSION RECEIVED
Thursday, February 15, 2007EXTENSION 2 GRANTED
Thursday, December 14, 2006EXTENSION 2 FILED
Thursday, December 14, 2006TEAS EXTENSION RECEIVED
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 24, 2006EXTENSION 1 GRANTED
Friday, July 21, 2006EXTENSION 1 FILED
Friday, July 21, 2006TEAS EXTENSION RECEIVED
Tuesday, January 24, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2005NOTICE OF PUBLICATION
Wednesday, September 7, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 2, 2005ASSIGNED TO LIE
Monday, August 29, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 29, 2005EXAMINERS AMENDMENT E-MAILED
Monday, August 29, 2005EXAMINERS AMENDMENT -WRITTEN
Monday, August 29, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, August 26, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 26, 2005EXAMINERS AMENDMENT E-MAILED
Friday, August 26, 2005EXAMINERS AMENDMENT -WRITTEN
Friday, May 6, 2005NON-FINAL ACTION E-MAILED
Friday, May 6, 2005NON-FINAL ACTION WRITTEN
Wednesday, May 4, 2005ASSIGNED TO EXAMINER
Friday, October 8, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

therafide epithelial cells tissues injury treatment preparations used pharmaceutical